Improving the care for myocardial infarction: editor's perspective.
Spertus
John
J
University of Missouri–Kansas City, Saint Luke’s Mid America Heart Institute, 4401 Wornall Rd., Kansas City, MO 64111, USA. spertusj@umkc.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006297:Health Services Accessibility; D006801:Humans; D009026:Mortality / Q000639:trends; D009203:Myocardial Infarction / Q000191:economics / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy*; D009204:Myocardial Revascularization; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D012040:Regional Health Planning; D014481:United States
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants